Physical Signs, Appearance, and Skin Care in CFC3

The physical appearance of a child with Cardiofaciocutaneous Syndrome 3 (CFC3) is shaped by the way the MAP2K1 mutation affects the development of the face, skin, hair, and bones. While every child is different—and some may even have very mild or “non-classical” features—there are several common physical and ectodermal (skin, hair, and nail) findings that help define this condition ^[1][2]. It is important to distinguish between features that simply shape a child’s unique appearance and health issues that cause discomfort or require treatment.

Craniofacial Features

The facial features associated with CFC often become more distinct as a child grows. These features reflect the underlying biological pathway that affects how the skull and facial structures form ^[2] and do not dictate a child’s intelligence or potential. Common structural findings include:

• Macrocephaly: A relatively large head size compared to the rest of the body ^[3].
• High Forehead: A prominent forehead with narrowing at the temples ^[4].
• Eye Features: Eyes that appear widely spaced (hypertelorism), drooping upper eyelids (ptosis), and skin folds covering the inner corners of the eyes (epicanthal folds) ^[4][5].
• Ear and Nose Features: Low-set ears that may be rotated backward, and a short nose with a broad bridge and upturned tip ^[2][4].

Ectodermal Findings: Skin and Hair

The skin and hair are among the most visible areas affected in CFC. These symptoms are collectively called ectodermal findings because the skin and hair develop from the same embryonic layer that is influenced by the RAS/MAPK pathway ^[4][6]. (Note: these percentages come from pooled studies of all CFC types).

Hair Abnormalities

• Sparse Eyebrows and Lashes: Many individuals with CFC have very thin or entirely absent eyebrows, especially on the outer edges ^[4].
• Texture and Growth: Hair is often very curly, wavy, or frizzy. It may also be sparse, slow-growing, or brittle ^[4][1].

Skin Conditions

• Keratosis Pilaris: Often referred to as “chicken skin,” these are small, rough bumps that typically appear on the arms, legs, and face ^[4].
• Ulerythema Ophryogenes: A specific form of keratosis pilaris that causes redness and scarring of the eyebrows, often leading to permanent hair loss in that area ^[4][6].
• Palmoplantar Hyperkeratosis: Thickening of the skin on the palms of the hands and soles of the feet. This can sometimes become painful or cause cracks (fissures) ^[4].
• Multiple Nevi (Moles): Many children develop numerous moles. While usually benign, they should be clinically monitored by a dermatologist based on the child’s individual risk factors ^[4][6].

Daily Management and Skin Care

Managing skin in CFC3 is about maintaining the skin’s barrier and reducing the discomfort caused by thickening and bumps.

1. Hydration is Key: Use thick, fragrance-free emollients (moisturizers) at least twice daily. Ointments and heavy creams are generally more effective than thin lotions ^[6].
2. Gentle Cleansing: Use “soap-free” cleansers to avoid stripping the skin of its natural oils.
3. Managing Bumps: For keratosis pilaris, your doctor may recommend mild keratolytics—creams containing ingredients like urea or lactic acid that help soften and dissolve the rough bumps. However, use caution as these can irritate sensitive skin; always follow age and body-surface guidelines from your clinician ^[6].
4. Specialized Care: If palmoplantar hyperkeratosis becomes severe and limits mobility, doctors sometimes consider systemic medications like oral acitretin. This is a powerful retinoid that is strictly prescribed and supervised by a pediatric dermatologist due to significant pediatric risks, including required liver and lipid monitoring, bone concerns, and teratogenicity ^[4]. It is an option of last resort, not a routine step.
5. What Doesn’t Work: In clinical observations, some treatments like topical sirolimus have not been effective for treating the redness and scarring of ulerythema ophryogenes ^[4].

Musculoskeletal Findings

Beyond the skin, the MAP2K1 mutation also affects the musculoskeletal system, which can impact how a child moves ^[7][8].

• Joint Laxity: Many children have “double-jointed” or very flexible joints. Conversely, some may develop contractures (tightening of muscles or tendons) over time ^[9][8].
• Hypotonia: Low muscle tone (feeling “floppy”) is common, which can lead to delays in sitting, crawling, and walking ^[10].
• Skeletal Deformities: Conditions like scoliosis (curvature of the spine) or kyphosis (rounded back) may develop as the child grows ^[11][7].
• Bone Health: Some individuals with CFC have lower bone mineral density. However, routine lab testing or DXA scans are not automatically required for every child. Bone assessment is individualized based on clinical risk factors such as a history of fractures, poor mobility, nutritional status, and the use of certain anti-seizure medications ^[12][13].